Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion

Şen N., Ozlu F., Akgül E., Kanat S., Cayci T., Turak O., et al.

ATHEROSCLEROSIS, cilt.219, ss.304-310, 2011 (SCI İndekslerine Giren Dergi)


Objectives: We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).